%PDF-1.4
%
42 0 obj
<>
endobj
39 0 obj
<>
endobj
127 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-14T16:12:52Z
2024-03-28T19:28:14-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T19:28:14-07:00
application/pdf
Heather
2001-743.oct02
uuid:37231f50-1dd2-11b2-0a00-f308275d6100
uuid:37231f52-1dd2-11b2-0a00-aa0000000000
endstream
endobj
28 0 obj
<>
endobj
29 0 obj
<>
endobj
43 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
154 0 obj
[159 0 R]
endobj
155 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
-0.00011 Tc 10 0 0 10 54 713.1616 Tm
(ACKNOWLEDGMENT)Tj
/TT1 1 Tf
0.1295 Tw 8 0 0 8 54 703.1616 Tm
(The authors thank Nada Jabado, MD, PhD, Mira Johri, PhD, MPH, and)Tj
0 Tc 0.2166 Tw 0 -1.25 TD
(Michel Rossignol, MD, MSc, for their thoughtful comments about the)Tj
0 Tw T*
(manuscript.)Tj
/TT0 1 Tf
-0.00011 Tc 10 0 0 10 54 659.1616 Tm
(REFERENCES)Tj
/TT1 1 Tf
0 Tc 0.0249 Tw 8 0 0 8 61 649.1616 Tm
[(1.)-875 (MacLennan )55 (AH, )18 (W)40 (ilson DH, )18 (T)70 (aylor )55 (A)80 (W)92 (. Prevalence and cost of)]TJ
1.675 -1.25 Td
[(alternative medicine in )55 (Australia. Lancet 1996;347:569-73.)]TJ
-1.675 -1.25 Td
[(2.)-875 (Bernstein JH, Shuval JT)74 (. Nonconventional medicine in Israel:)]TJ
1.675 -1.25 Td
(consultation patterns of the Israeli population and attitudes of)Tj
T*
(primary care physicians. Soc Sci Med 1997;44:1341-8.)Tj
-1.675 -1.25 Td
[(3.)-875 (Millar )18 (WJ. Use of alternative health care practitioners by)]TJ
1.675 -1.25 Td
(Canadians. Can J Public Health 1997;88:154-8.)Tj
-1.675 -1.25 Td
[(4.)-875 (Gordon NP)111 (, Sobel DS, )18 (T)70 (arazona EZ. Use of and interest in)]TJ
1.675 -1.25 Td
(alternative therapies among adult primary care clinicians and adult)Tj
T*
[(members in a lar)18 (ge health maintenance or)18 (ganization. )18 (W)80 (est J Med)]TJ
0 Tw T*
(1998;169:153-61.)Tj
0.02499 Tw -1.675 -1.25 Td
[(5.)-875 (Eisenber)18 (g DM, Davis RB, Ettner SL, et al. )18 (T)35 (rends in alternative)]TJ
1.675 -1.25 Td
(medicine use in the United States, 1990-1997: results of a )Tj
-0.00011 Tc T*
[(follow-up national survey)65 (. JAMA)-220 (1998;280:1569-75.)]TJ
-1.675 -1.25 Td
[(6.)-875 (Ramos-Remus C, Gutierrez-Urena S, Davis P)111 (. Epidemiology of)]TJ
0 Tc 1.675 -1.25 Td
[(complementary and alternative practices in rheumatology)65 (. Rheum)]TJ
T*
[(Dis Clin North )55 (Am 1999;25:789-804.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(7.)-875 (Eisenber)18 (g DM, Kessler RC, Foster C, Norlock FE, Calkins DR,)]TJ
0 Tc 1.675 -1.25 Td
[(Delbanco )18 (TL. Unconventional medicine in the United States.)]TJ
T*
(Prevalence, costs, and patterns of use. N Engl J Med 1993;)Tj
0 Tw T*
(328:246-52.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(8.)-875 (Rao JK, Mihaliak K, Kroenke K, Bradley J, )18 (T)35 (ierney )18 (WM,)]TJ
1.675 -1.25 Td
[(W)80 (einber)18 (ger M. Use of complementary therapies for arthritis among)]TJ
0 Tc T*
[(patients of rheumatologists. )55 (Ann Intern Med 1999;131:409-16.)]TJ
-1.675 -1.25 Td
[(9.)-875 (Angell M, Kassirer JP)111 (. )55 (Alternative medicine \227 the risks of untested)]TJ
1.675 -1.25 Td
(and unregulated remedies. N Engl J Med 1998;339:839-41.)Tj
-2.175 -1.25 Td
[(10.)-875 (Panush RS. )55 (American College of Rheumatology position statement.)]TJ
2.175 -1.25 Td
(Complementary and alternative therapies for rheumatic diseases.)Tj
T*
[(Rheum Dis Clin North )55 (Am 2000;26:189-92.)]TJ
-0.00011 Tc -2.1381 -1.25 Td
[(1)37 (1.)-875 (Blais R, Maiga )55 (A, )55 (Aboubacar )55 (A. How dif)18 (ferent are users and)]TJ
0 Tc 2.1381 -1.25 Td
(non-users of alternative medicine? Can J Public Health)Tj
0 Tw T*
(1997;88:159-62.)Tj
0.0249 Tw -2.175 -1.25 Td
[(12.)-875 (Astin JA. )18 (Why patients use alternative medicine: results of a)]TJ
2.175 -1.25 Td
[(national study)65 (. JAMA)-220 (1998;279:1548-53.)]TJ
-2.175 -1.25 Td
[(13.)-875 (Kramer N. )18 (Why I would not recommend complementary or)]TJ
2.175 -1.25 Td
[(alternative therapies: a physician\222)55 (s perspective. Rheum Dis Clin)]TJ
-0.02991 Tw T*
[(North Am )-55 (1999;25:833-43.)]TJ
0.02499 Tw -2.175 -1.25 Td
[(14.)-875 (Bloom BS, Retbi )55 (A, Dahan S, Jonsson E. Evaluation of randomized)]TJ
2.175 -1.25 Td
(controlled trials on complementary and alternative medicine. Int J)Tj
-0.00011 Tc T*
[(T)70 (echnol )55 (Assess Health Care 2000;16:13-21.)]TJ
0 Tc -2.175 -1.25 Td
[(15.)-875 (Kanning M. )18 (Why I would want to use complementary and)]TJ
2.175 -1.25 Td
[(alternative therapy: a patient\222)55 (s perspective. Rheum Dis Clin North)]TJ
T*
(Am 1999;25:823-31.)Tj
-2.175 -1.25 Td
[(16.)-875 (Neims )55 (AH. )18 (Why I would recommend complementary or alternative)]TJ
2.175 -1.25 Td
[(therapies: a physician\222)55 (s perspective. Rheum Dis Clin North )55 (Am)]TJ
0 Tw T*
(1999;25:845-53.)Tj
0.02499 Tw -2.175 -1.25 Td
[(17.)-875 (Furnham )55 (A, Smith C. Choosing alternative medicine: a comparison)]TJ
2.175 -1.25 Td
(of the beliefs of patients visiting a general practitioner and a)Tj
T*
(homeopath. Soc Sci Med 1988;26:685-9.)Tj
-2.175 -1.25 Td
[(18.)-875 (Furnham )55 (A, Forey J. )18 (The attitudes, behaviors and beliefs of patients)]TJ
2.175 -1.25 Td
(of conventional vs. complementary \(alternative\) medicine. J Clin)Tj
T*
(Psychol 1994;50:458-69.)Tj
-2.175 -1.25 Td
[(19.)-875 (Sutherland LR, )18 (V)111 (erhoef MJ. )18 (Why do patients seek a second opinion)]TJ
2.175 -1.25 Td
(or alternative medicine? J Clin Gastroenterol 1994;19:194-7.)Tj
-2.175 -1.25 Td
[(20.)-875 (V)60 (incent C, Furnham )55 (A. )18 (Why do patients turn to complementary)]TJ
2.175 -1.25 Td
[(medicine? )55 (An empirical study)65 (. Br J Clin Psychol 1996;35:37-48.)]TJ
-2.175 -1.25 Td
[(21.)-875 (Kaptchuk )18 (TJ, Eisenber)18 (g DM. )18 (The persuasive appeal of alternative)]TJ
2.175 -1.25 Td
[(medicine. )55 (Ann Intern Med 1998;129:1061-5.)]TJ
-0.00011 Tc 30.825 79.421 Td
[(22.)-875 (Cronan )18 (T)80 (A, Kaplan RM, Posner L, Blumber)18 (g E, Kozin F)80 (.)]TJ
0 Tc 2.175 -1.25 Td
(Prevalence of the use of unconventional remedies for arthritis in a)Tj
T*
[(metropolitan community)65 (. )55 (Arthritis Rheum 1989;32:1604-7.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(23.)-875 (Cronan )18 (T)80 (A, Kaplan RM, Kozin F)80 (. Factors af)18 (fecting unprescribed)]TJ
0 Tc 2.175 -1.25 Td
[(remedy use among people with self-reported arthritis. )55 (Arthritis Care)]TJ
T*
(Res 1993;6:149-55.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(24.)-875 (Arcury )18 (T)80 (A, Bernard SL, Jordan JM, Cook HL. Gender and ethnic)]TJ
0 Tc 2.175 -1.25 Td
[(dif)18 (ferences in alternative and conventional arthritis remedy use)]TJ
T*
[(among community-dwelling rural adults with arthritis. )55 (Arthritis)]TJ
T*
(Care Res 1996;9:384-90.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(25.)-875 (Cassileth BR, Lusk EJ, Strouse )18 (TB, Bodenheimer BJ.)]TJ
0 Tc 2.175 -1.25 Td
[(Contemporary unorthodox treatments in cancer medicine. )55 (A)-220 (study)]TJ
T*
[(of patients, treatments, and practitioners. )55 (Ann Intern Med)]TJ
0 Tw T*
(1984;101:105-12.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(26.)-875 (Fairfield KM, Eisenber)18 (g DM, Davis RB, Libman H, Phillips RS.)]TJ
0 Tc 2.175 -1.25 Td
[(Patterns of use, expenditures, and perceived ef)18 (ficacy of)]TJ
T*
[(complementary and alternative therapies in HIV)92 (-infected patients.)]TJ
T*
(Arch Intern Med 1998;158:2257-64.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(27.)-875 (V)60 (isser GJ, Peters L, Rasker JJ. Rheumatologists and their patients)]TJ
0 Tc 2.175 -1.25 Td
(who seek alternative care: an agreement to disagree. Br J)Tj
T*
(Rheumatol 1992;31:485-90.)Tj
-2.175 -1.25 Td
[(28.)-875 (Oldendick R, Coker )55 (AL, )18 (W)40 (ieland D, et al. Population-based survey)]TJ
2.175 -1.25 Td
(of complementary and alternative medicine usage, patient )Tj
T*
(satisfaction, and physician involvement. South Carolina)Tj
T*
[(Complementary Medicine Program Baseline Research )18 (T)70 (eam. South)]TJ
T*
(Med J 2000;93:375-81.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(29.)-875 (Astin JA, Pelletier KR, Marie )55 (A, Haskell )18 (WL. Complementary and)]TJ
0 Tc 2.175 -1.25 Td
(alternative medicine use among elderly persons: one-year analysis)Tj
T*
[(of a Blue Shield Medicare supplement. J Gerontol )55 (A)-220 (Biol Sci Med)]TJ
T*
(Sci 2000;55:M4-9.)Tj
-2.175 -1.25 Td
[(30.)-875 (Catlin G, )18 (W)40 (ill P)111 (. )18 (The National Population Health Survey: highlights)]TJ
2.175 -1.25 Td
(of initial developments. Health Rep 1992;4:313-9.)Tj
-2.175 -1.25 Td
[(31.)-875 (T)70 (ambay JL, Catlin G. Sample design of the National Population)]TJ
2.175 -1.25 Td
[(Health Survey)65 (. Health Rep 1995;7:29-38.)]TJ
-2.175 -1.25 Td
[(32.)-875 (Statistics Canada. National Population Health Survey Overview)]TJ
-0.00011 Tc 2.175 -1.25 Td
(1996-1997. Ottawa: Ministry of Industry; 1998.)Tj
0 Tc -2.175 -1.25 Td
[(33.)-875 (Statistics Canada. National Population Health Survey)65 (. Household)]TJ
-0.00011 Tc 2.175 -1.25 Td
(component 1996-1997. User guide. Ottawa: Ministry of Industry;)Tj
0 Tc 0 Tw T*
(1998.)Tj
0.02499 Tw -2.175 -1.25 Td
[(34.)-875 (Stata Corp. Stata statistical software: Release 6.0. College Station,)]TJ
2.175 -1.25 Td
(TX: Stata Corp.; 1999.)Tj
-2.175 -1.25 Td
[(35.)-875 (Raftery )55 (AE. Bayesian model selection in social research. Sociol)]TJ
2.175 -1.25 Td
[(Method 1995;25:1)37 (1)37 (1-63.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(36.)-875 (Kass RE, Raftery )55 (AE. Bayes factors. J )55 (Am Stat )55 (Assoc 1995;)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(90:773-95.)Tj
0.02499 Tw -2.175 -1.25 Td
[(37.)-875 (Robinson JR, )37 (Y)100 (oung )18 (TK, Roos LL, Gelskey DE. Estimating the)]TJ
2.175 -1.25 Td
(burden of disease. Comparing administrative data and self-reports.)Tj
T*
(Med Care 1997;35:932-47.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(38.)-875 (Moore )55 (AD, Petri MA, Manzi S, et al. )18 (The use of alternative medical)]TJ
0 Tc 2.175 -1.25 Td
[(therapies in patients with systemic lupus erythematosus. )18 (T)35 (rination)]TJ
T*
[(Study Group. )55 (Arthritis Rheum 2000;43:1410-8.)]TJ
-2.175 -1.25 Td
[(39.)-875 (Boisset M, Fitzcharles MA. )55 (Alternative medicine use by )]TJ
2.175 -1.25 Td
(rheumatology patients in a universal health care setting. )Tj
T*
(J Rheumatol 1994;21:148-52.)Tj
-2.175 -1.25 Td
[(40.)-875 (MacLean CH, Louie R, Leake B, et al. Quality of care for patients)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(with rheumatoid arthritis. JAMA)-220 (2000;284:984-92.)]TJ
-2.175 -1.25 Td
[(41.)-875 (Chandola )55 (A, )37 (Y)100 (oung )37 (Y)129 (, McAlister J, )55 (Axford JS. Use of )]TJ
0 Tc 2.175 -1.25 Td
(complementary therapies by patients attending musculoskeletal)Tj
T*
(clinics. J R Soc Med 1999;92:13-6.)Tj
-2.175 -1.25 Td
[(42.)-875 (V)111 (ecchio PC. )55 (Attitudes to alternative medicine by rheumatology)]TJ
2.175 -1.25 Td
(outpatient attenders. J Rheumatol 1994;21:145-7.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(43.)-875 (Thomas KJ, Carr J, )18 (W)80 (estlake L, )18 (W)40 (illiams BT)74 (. Use of non-orthodox)]TJ
0 Tc 2.175 -1.25 Td
(and conventional health care in Great Britain. BMJ 1991;)Tj
0 Tw T*
(302:207-10.)Tj
/TT2 1 Tf
0.02499 Tw -35.4875 -6.0681 Td
[(Fautr)37 (el, et al: Complementary medicine and arthritis)]TJ
0 Tw 60.9375 -0.0313 Td
(2441)Tj
ET
Q
Q
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS1 CS 0 0 0 1 SCN
/GS1 gs
54 54 m
558 54 l
S
Q
Q
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS1 cs 0 0 0 0 scn
104.25 58.54 407.5 -10.83 re
f*
Q
Q
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS1 CS 0 0 0 1 SCN
0.5 w
104.25 58.54 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
ET
/GS2 gs
BT
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
108 0 obj
<>
endobj
133 0 obj
<>
endobj
19 0 obj
<>
endobj
50 0 obj
<>
endobj
45 0 obj
<>
endobj
47 0 obj
<>
endobj
75 0 obj
<>stream
HVpTι&B $pK"&Y˅W@c<HxLHaȠU@@B&t(0@<,uyt@ Qq~w^:qO?Ϟ@TAA{s[TΥ<3*v.+@PZ1(9K ?fYIx&=}˨9(w-+_sGהjԜEAJcʃ*-`y$]fǐOZ7i붽b~I߿dB:dZ>+H3F
kXVR-hPq QnpV}A. CbV0e8F4 ӑK߿r2c74cgaqHZ'XUuo 73R~-jrzIDAϓvhYx
88<4;(9]H{ `#1U.Tj-E~qB=I2jm[JhHEQ;3PuKḄ"FCEX!
)neGӺX+K\yH~*ju5DNVh|Uh~ޭ'Gٙhp(Md38'ce40y^T(s%ok ?dz:d\+e=s{؎xv<3}'q_urhM='/R8҄U®R,UbxCT^8J~9E.<%Wu*.:B-Twj4mVr3/Rxj2h9X+êZ[:vH%0ؑLvu4rMtٛEs3 ;٧y0Y\ff?.#, Tֹ#sɌF0"_d1ULL%q5GxYnnqP\7-W1e;3BsyR%ߑ{r4^yFJ)JPT+۔qIWuD}[=Nkek|XwZmvV0su*g--i! F\c"O-!>)r85
EbImR$eװ.|{a|iN+:U!~7Wh147/_Oݳsgef<.KԔN;]\61[EG9H,1<SM7Ft۲""`T
7IO=Ki<q rg>C7^'
^5
t)Y
;t_RW7E@+B~s;#
.-Kd{d3;ވMIͼ~U2En1݄1lٲ=t暎\g `;khM]2cd#eL|R#ʷ5L,
giVl\Ciԋ:c~S``ݦkSoNٚ,6eY<9dbbמdO?j>=4o;AoMXwV}Ҳ.==Ԟ5Yެ?uΣ&</0S/Io0?EiFBqjiqltIMEHnCifdO DjC">JQX*䱎٬elu)UͲY`ʀmo[Xn{a+oF?iW6 \VtBx[xgT2EYk=)B~[P>l\!1PT`P'trZBM탢u IAR
4UT!9 Emf(Tjԕ͛73ovg$~ꖰ=#įBYz)# ƣh!R&>tXax^5x^~<
QA=,GV>h9}Z؉׀ &[wxIuyiBP1~aq=X=-=elC/?ޯnt ACLPpcP8;eȫYI(?W,~>Ji mY0Z $[;71;d%ECKNռcD"+V0
1:#tGƜc!2
D*hN&jE'2ur7Tdd ]'Ru@NL:! Nu d `zNv 2 1Ȅ٥Ud9~@
w^͵kke.|.-ZzE2ӭ\V>V.nTpעfmUZVeUiU*EI3\f'XլT4+͊%@g3Z2
r,)